ATAlexander Tamashevski

Alexander Tamashevski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alexander Tamashevski has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Photoluminescent Detection of Human T-Lymphoblastic Cells by ZnO Nanorods

    by Alexander Tamashevski, Yuliya Harmaza, Ekaterina Slobozhanina, Roman Viter, Igor Iatsunskyi

    The precise detection of cancer cells currently remains a global challenge. One-dimensional (1D) semiconductor nanostructures (e.g., ZnO nanorods) have attracted attention due to their potential use in cancer biosensors. In the current study, it was demonstrated that the possibility of a photoluminescent detection of human leukemic T-cells by using a zinc oxide nanorods (ZnO NRs) platform. Monoclonal antibodies (MABs) anti-CD5 against a cluster of differentiation (CD) proteins on the pathologic cell surface have been used as a bioselective layer on the ZnO surface. The optimal concentration of the protein anti-CD5 to form an effective bioselective layer on the ZnO NRs surface was selected. The novel biosensing platforms based on glass/ZnO NRs/anti-CD5 were tested towards the human T-lymphoblast cell line MOLT-4 derived from patients with acute lymphoblastic leukemia. The control tests towards MOLT-4 cells were performed by using the glass/ZnO NRs/anti-IgG2a system as a negative control. It was shown that the photoluminescence signal of the glass/ZnO NRs/anti-CD5 system increased after adsorption of T-lymphoblast MOLT-4 cells on the biosensor surface. The increase in the ZnO NRs photoluminescence intensity correlated with the number of CD5-positive MOLT-4 cells in the investigated population (controlled by using flow cytometry). Perspectives of the developed ZnO platforms as an efficient cancer cell biosensor were discussed.


  • Open Access

    MOLECULAR NATURE OF CYTOTOXICITY OF ZINC OXIDE NANOSTRUCTURES

    by Yu. M. Harmaza, A. V. Tamashevski, E. I. Slobozhanina

    A comparative analysis of the molecular process of nanostructured zinc oxide of different shape (rod and spherical particle) and zinc chloride as a source of free ions on human lymphocytes was carried out. Our data indicated that ZnO nanostructures induced a decrease in the lymphocyte viability and an increase in the intracellular labile Zn2+ pool in a concentration-dependent manner after 20 and 40 h incubation with cells. It was found that ZnO NRs have the lowest cytotoxicity, but ZnCl2 - the highest. The Zn-mediated activation of free radical processes - ROS accumulation in the cells is a possible mechanism of the cytotoxic action of these agents. Thus, the shape of ZnO nanomaterial and its ability "to shed" zinc ions make the main contribution to the detected molecular and membrane process on human lymphocytes in vitro.


  • Open Access

    Membrane effects of zinc oxide nanorods and nanoparticles in human lymphocytes

    by Yu. M. Harmaza, A. V. Tamashevski, E. I. Slobozhanina, Ю. М. Гармаза

    Мембранные эффекты воздействия наностержней и наночастиц оксида цинка на лимфоциты человека


  • Open Access

    THE INFLUENCE OF CELL AND PLASMA HEMOSTASIS AND BIOMARKER LEVELS ON CLINICAL OUTCOMES IN PATIENTS WITH UNSTABLE ANGINA AND RESISTANCE TO ANTIPLATELET AGENTS

    by L. G. Gelis, E. A. Medvedeva, I. I. Russkich, I. V. Lazareva, Т. В. Русак, A. V. Tamashevsky

    РЕЗЮМЕ Цель: оценить влияние нарушений клеточно- плазменного гемостаза и уровня биомаркеров на клинические исходы и разработать лабораторные диагностические критерии прогноза повторных коронарных событий у пациентов с нестабильной стенокардией. Материал и методы: обследовано 124 пациента с нестабильной стенокардией. Всем пациентам выполнялись: общий анализ крови, определение уровня определение уровня TnI, определение маркеров воспаления (С-реактивного белка (СРБ)), уровня миелопероксидазы, фактора Виллебранда, уровень тромбина, фибриногена (Фг), антитромбина III (АТ III), Д-димеров, фактора Ха), выполнение агрегатограмм на анализаторе Мультиплейт и определение активности тромбоцитов с помощью метода проточной цитометрии, а также ЭКГ, ЭхоКГ, ХМ-ЭКГ, коронароангиография. Результаты: разработаны независимые предикторы риска развития повторных коронарных событий для пациентов с нестабильной стенокардией: пороговые значения для оценки агрегационной способности тромбоцитов на анализаторе Мультиплейт-АБР^тест (AUC) >52 U, ADP-тест (AUC) >60 U; пиковая концентрация тромбина >294,5 нМ, размер тромбоцита - MPV в ОАК >9,6 fl, миелопероксидаза >316 пмоль/л, высокочувствительного СРБ >3,8 г/л, а также уровень тропо-нина I >0,07 нг/мл. Разработана скрининговая модель прогнозирования повторных коронарных событий после перенесенной нестабильной стенокардии. Среди лиц, включенных в исследование, выявлено, что у 18 (14,5%) пациентов регистрировалось снижение чувствительности к аспирину в стандартной дозе 75 мг, у 24 пациентов (19,4%) к клопидогрелу 75 мг и у 8 лиц (6,5%) - к аспирину и клопидогрелу. Выявлено, что наличие резистентности к АСК и/или клопидогрелу более чем в 2,5 [ДИ 2,0; 2,8] раза увеличивает относительный риск развития повторных ишемиче-ских осложнений. Выводы: разработаны независимые предикторы риска развития повторных коронарных событий для пациентов с нестабильной стенокардией: AUC ASPI-теста >52 U, AUC ADP-теста >60 U; пиковая концентрация тромбина >294,5 нМ, размер тромбоцита - MPV >9,6 fl, миелопероксидаза >316 пмоль/л, высокочувствительный СРБ >3,8 г/л, а также уровень тропо-нина I >0,07 нг/мл. Ключевые слова: нестабильная стенокардия, резистентность к антиагрегантам, агрегатограмма, клеточно-плазмен-ный гемостаз


  • The transport activity of P-glycoprotein upon a change of the redox balance in lymphocytes of patients with chronic B-lymphocytic leukemia

    by A. V. Tamashevski, Y. M. Harmaza, E. I. Slobozhanina, A. I. Svirnovski

    The effect of drugs used in the treatment of chronic B-lymphocytic leukemia on the functional activity of P-glycoprotein, which is a membrane transporter associated with the phenomenon of multiple drug resistance, in B-lymphocytes of leukemia patients has been investigated. The level of reactive oxygen species and the content of low molecular weight antioxidants in the leukemic cells during the metabolic processing of chemotherapy drugs has been assessed. The degree of involvement of low molecular weight antioxidants in the maintenance of redox balance in the lymphocytes of drug-treated leukemia patients has been characterized. Variation of the levels of reactive oxygen species in leukemic B-lymphocytes within a certain range, as well as the subsequent return of these values to the levels of intact cells, was shown to enhance the P-glycoprotein transport activity. The viability of leukemic B-cells decreased upon exposure to antitumor compounds and depended on the redox balance. No statistically significant correlation between the P-glycoprotein transport activity and the viability of lymphocytes during the detoxification from drugs in B-cell chronic lymphocytic leukemia patients has been detected; however, the transport activity of the protein was directly correlated to the viability of leukemia cells within 15 h after exposure of the cells to H2O2.

  • Effect of cholesterol on the functional activity of proteins responsible for the resistance of human lymphocytes to xenobiotics

    by A. V. Tamashevski, N. M. Kozlova, N. V. Goncharova, G. P. Zubritskaya, E. I. Slobozhanina

    The influence of agents modifying cholesterol in plasma membranes on the functional activity of transporter proteins (P-glycoprotein (P-gp) and multidrug resistance protein 1 (MRP1)) in human lymphocytes has been studied. It was shown that changes in the lateral distribution of cholesterol using the polyene antibiotic filipin, which disturbs the structure and function of glycolipid microdomains in plasma membranes of lymphocytes lead to a decrease in the transport activity of both P-gp and MRP1. It was found that the treatment of human lymphocytes with the cyclic oligosaccharide methyl-β-cyclodextrin, which leads to cholesterol depletion and reduction of lipid bilayer microviscosity in membranes of these cells, also decreases the functional activity of these proteins. It was concluded that the transport activity of P-gp and MRP1 depends on the modification of cholesterol in the membranes of human lymphocytes, i.e., is closely associated with the level of cholesterol and its lateral distribution.

  • Apoptosis of Peripheral Human Blood Lymphocytes Induced by Physical‐Chemical Influences and Generation of Reactive Oxygen Species

    by A.Exander Tamashevski, Ekaterina Slobozhanina, Tatiana Sergienko, A.Exandra Bakkun, Irina Taras, Irina Medved, A.Cadi Svirnovski

    The sensitivity of peripheral blood lymphocytes of healthy people (blood donors) to induced apoptotic processes and reactive oxygen species production under physical-chemical influences was evaluated in vitro.